SAN FRANCISCO
EOS, a private genomic research company, will relocate from its 31,000-sf space in South San Francisco, to a 82,000-sf building at Slough Estates USA's $250 million development at Oyster Point. Construction of the facility is scheduled to begin in July 2001.